| Literature DB >> 26306387 |
Vincent Oladele Adeniyi1,2, Elza Thomson3, Daniel Ter Goon4, Idowu Anthony Ajayi5.
Abstract
BACKGROUND: Despite the overwhelming evidence confirming the morbidity and mortality benefits of early initiation of highly active anti-retroviral therapy (HAART) in HIV-infected infants, some children are still disadvantaged from gaining access to care. The understanding of the maternal perspective on early infant HIV diagnosis and prompt initiation of HAART has not been adequately explored, especially in the rural communities of South Africa. This study explores the perspectives of mothers of HIV-exposed infants with regard to early infant diagnosis (EID) through a lens of social and structural barriers to accessing primary healthcare in OR Tambo district, Eastern Cape Province, South Africa.Entities:
Mesh:
Year: 2015 PMID: 26306387 PMCID: PMC4549931 DOI: 10.1186/s12887-015-0414-8
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Fig. 1Cascade of EID Services
Socio-demographic characteristics of participants
| Variables | Individual interviews ( | Focus group discussion ( |
|---|---|---|
| Age (years) | ||
| 18–22 | 2 (8 %) | 2 (12 %) |
| 23–27 | 6 (25 %) | 6 (38 %) |
| 28–32 | 11 (46 %) | 7 (44 %) |
| >32 | 5 (21 %) | 1 (6 %) |
| Marital status | ||
| Single | 14 (58 %) | 10 (63 %) |
| Married | 10 (42 %) | 6 (37 %) |
| Level of education | ||
| < Grade 6 | 1 (4 %) | - |
| Grade 6–9 | 16 (67 %) | 5 (31 %) |
| Grade 10–12 | 5 (21 %) | 11 (69 %) |
| Tertiary | 2 (8 %) | - |
| Employment status | ||
| Employed | 1 (4 %) | - |
| Unemployed | 23 (96 %) | 16 (100 %) |
| Total number of children (alive or dead) | ||
| 1 | 7 (29 %) | 8 (50 %) |
| 2 | 7 (29 %) | 5 (31 %) |
| 3 or more | 10 (42 %) | 3 (19 %) |
| Duration of HIV diagnosis (years) | ||
| <1 | 9 (38 %) | 2 (12 %) |
| 1–3 | 7 (29 %) | 11 (69 %) |
| >3 | 10 (33 %) | 3 (19 %) |
| Currently on HAART | ||
| Yes | 14 (58 %) | 9 (56 %) |
| No | 10 (42 %) | 7 (44 %) |
HAART highly active antiretroviral therapy
Summary of themes and sub-themes
| Themes | Sub-themes |
|---|---|
| What do you know about HIV infection in infants? | Infection in mother can be transmitted to the child |
| Time of infection during pregnancy, delivery and breastfeeding | |
| Window period in mother | |
| Other contributory factors of MTCT: low CD4 count, mixed feeding, prolonged breast feeding, | |
| HAART initiation in mothers | |
| How could you prevent MTCT of HIV? | Time of initiation of HAART in pregnancy |
| Adherence to treatment | |
| Probable risk of transmission despite HAART | |
| Where could you obtain the infant test and when should you take your child for the test? | Time of the test |
| Where the service is provided | |
| Time of HAART initiation in infants | |
| If an HIV infected child is not treated, what can happen to the child? | Vulnerability to infections |
| Skin changes | |
| Poor growth | |
| Poor mental development | |
| Death | |
| Would you like to have HIV test on your child? | Willingness to test |
| Readiness to test | |
| Reactions to HIV test in their children | |
| DO you have any fears about HIV test in your child? | Reasons for fear: |
| What are your expectations over the waiting period for the result? | Embarrassment of having a child infected with HIV |
| What people in the community might say | |
| Child might depend on medications to live | |
| Child might be falling sick | |
| Child might die | |
| Reactions towards positive results | |
| Confirmation of return date and willingness to collect results | |
| Should HIV test be mandatory in the community | Benefits to other children |
| Recommend HIV test to other children in your community |